YU51802A - Nova terapeutska primena enoksaparina - Google Patents

Nova terapeutska primena enoksaparina

Info

Publication number
YU51802A
YU51802A YU51802A YUP51802A YU51802A YU 51802 A YU51802 A YU 51802A YU 51802 A YU51802 A YU 51802A YU P51802 A YUP51802 A YU P51802A YU 51802 A YU51802 A YU 51802A
Authority
YU
Yugoslavia
Prior art keywords
enoxaparing
therapeutic use
novel therapeutic
novel
enoxaparin
Prior art date
Application number
YU51802A
Other languages
English (en)
Inventor
Veronique Mary
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU51802A publication Critical patent/YU51802A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ovaj pronalazak se odnosi na primenu enoksaparina za lečenje cerebralne ishemije.[The invention concerns the use of enoxaparin for treating cerebral ischemia.
YU51802A 2000-01-06 2001-01-03 Nova terapeutska primena enoksaparina YU51802A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (fr) 2000-01-06 2000-01-06 Nouvelle application therapeutique de l'enoxaparine

Publications (1)

Publication Number Publication Date
YU51802A true YU51802A (sh) 2005-06-10

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
YU51802A YU51802A (sh) 2000-01-06 2001-01-03 Nova terapeutska primena enoksaparina

Country Status (30)

Country Link
EP (1) EP1248638B1 (sh)
JP (1) JP2003519185A (sh)
KR (1) KR20020069240A (sh)
CN (1) CN1400905A (sh)
AR (1) AR026804A1 (sh)
AT (1) ATE344671T1 (sh)
AU (1) AU784656B2 (sh)
BR (1) BR0107442A (sh)
CA (1) CA2396178A1 (sh)
CZ (1) CZ20022303A3 (sh)
DE (1) DE60124373T2 (sh)
DK (1) DK1248638T3 (sh)
EA (1) EA006035B1 (sh)
EE (1) EE200200374A (sh)
ES (1) ES2275648T3 (sh)
FR (1) FR2803522B1 (sh)
HK (1) HK1052649A1 (sh)
HR (1) HRP20020573A2 (sh)
HU (1) HUP0204040A3 (sh)
IL (1) IL150477A0 (sh)
MX (1) MXPA02006672A (sh)
NO (1) NO20023243D0 (sh)
NZ (1) NZ520283A (sh)
PL (1) PL357192A1 (sh)
PT (1) PT1248638E (sh)
SK (1) SK9612002A3 (sh)
UA (1) UA75587C2 (sh)
WO (1) WO2001049298A2 (sh)
YU (1) YU51802A (sh)
ZA (1) ZA200205415B (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007003121A1 (es) * 2006-10-30 2008-05-16 Aventis Pharma Sa Uso de una dosis de 40 mg de enoxaparina sodica como minimo para tratar a un paciente de 65 anos de edad o mayor con ictus isquemico agudo o una puntuacion media de 10 o superior en la escala de nih para el ictus.
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
PL357192A1 (en) 2004-07-26
NO20023243L (no) 2002-07-04
DE60124373D1 (de) 2006-12-21
HK1052649A1 (zh) 2003-09-26
UA75587C2 (en) 2006-05-15
EP1248638B1 (fr) 2006-11-08
AU784656B2 (en) 2006-05-18
EE200200374A (et) 2003-12-15
AR026804A1 (es) 2003-02-26
CN1400905A (zh) 2003-03-05
WO2001049298A2 (fr) 2001-07-12
FR2803522B1 (fr) 2004-01-02
ES2275648T3 (es) 2007-06-16
ATE344671T1 (de) 2006-11-15
BR0107442A (pt) 2002-10-08
CZ20022303A3 (cs) 2002-11-13
IL150477A0 (en) 2002-12-01
DE60124373T2 (de) 2007-08-30
HUP0204040A2 (hu) 2003-04-28
AU3183001A (en) 2001-07-16
HRP20020573A2 (en) 2003-10-31
WO2001049298A3 (fr) 2002-04-04
CA2396178A1 (fr) 2001-07-12
PT1248638E (pt) 2007-02-28
EP1248638A2 (fr) 2002-10-16
HUP0204040A3 (en) 2003-05-28
ZA200205415B (en) 2003-10-13
DK1248638T3 (da) 2007-03-19
EA006035B1 (ru) 2005-08-25
MXPA02006672A (es) 2002-09-30
NZ520283A (en) 2004-09-24
JP2003519185A (ja) 2003-06-17
KR20020069240A (ko) 2002-08-29
NO20023243D0 (no) 2002-07-04
EA200200750A1 (ru) 2003-02-27
SK9612002A3 (en) 2002-12-03
FR2803522A1 (fr) 2001-07-13

Similar Documents

Publication Publication Date Title
BG108137A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
HK1105948A1 (en) Aspirin triggered lipid mediators
DE60112974D1 (en) Carbolinderivate
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
IL151132A0 (en) Pteridine compounds for the treatment of psoriasis
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
EP1446012A4 (en) Bacteriolytic combination therapy for the treatment of tumors
HK1142833A1 (en) Methods for the treatment of cellular proliferative disorders
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
DE60216233D1 (en) Carbolinderivate
HUP0500424A2 (en) Combination therapy for the treatment of cancer
MY124786A (en) Bis-arylsulfones
PL368556A1 (en) Methods for treating or preventing skin disorders using cd2-binding agents
TW200510398A (en) Novel compounds
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
MXPA03006412A (es) Metodos para administrar analogos de epotilona para tratamiento de cancer.
YU51802A (sh) Nova terapeutska primena enoksaparina
WO2002039958A3 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2001248346A1 (en) Use of CDP-choline for the prophylactic treatment of cerebral ischemia
HU0201738D0 (sh)
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.